0001209191-23-016774.txt : 20230307 0001209191-23-016774.hdr.sgml : 20230307 20230307163702 ACCESSION NUMBER: 0001209191-23-016774 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230303 FILED AS OF DATE: 20230307 DATE AS OF CHANGE: 20230307 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: White Marvin L CENTRAL INDEX KEY: 0001493324 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37746 FILM NUMBER: 23713098 MAIL ADDRESS: STREET 1: 2273 RESEARCH BLVD STREET 2: SUITE 400 CITY: ROCKVILLE STATE: MD ZIP: 20850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aptevo Therapeutics Inc. CENTRAL INDEX KEY: 0001671584 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 811567056 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2401 4TH AVE. STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: 206-838-0500 MAIL ADDRESS: STREET 1: 2401 4TH AVE. STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-03-03 0 0001671584 Aptevo Therapeutics Inc. APVO 0001493324 White Marvin L C/O APTEVO THERAPEUTICS INC. 2401 4TH AVENUE, SUITE 1050 SEATTLE WA 98121 1 1 0 0 President and CEO Common Stock 2023-03-03 4 M 0 9582 A 40137 D Restricted Stock Unit 2023-03-03 4 M 0 9582 0.00 D Common Stock 9582 19168 D Restricted Stock Unit 2023-03-03 4 A 0 38750 0.00 A Common Stock 38750 38750 D Stock Option (right to buy) 2.15 2023-03-03 4 A 0 38750 0.00 A 2033-03-02 Common Stock 38750 38750 D Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis. On June 7, 2022, the reporting person was granted 28,750 RSUs, vesting in three approximately equal annual installments beginning on March 3, 2023. The RSUs vest in three approximately equal annual installments beginning on March 2, 2024. The option vests in three approximately equal annual installments beginning on March 2, 2024. /s/ SoYoung Kwon, Attorney-in-Fact 2023-03-07